Amarin Corporation plc (NASDAQ: AMRN) is going to be participating in two investor conferences taking place during the month of June. Webcasts of both presentations will be made available through wsw.com.
The Interim CEO of Amarin, Dr. Declan Doogan, is going to be participating in the Jefferies 2010 Life Sciences Conference. Dr. Doogan is scheduled to deliver their presentation at 2:30pm (ET) on June 8, 2010. The Conference is being held in NYC at the Grand Hyatt Hotel.
Top Best Penny Stocks, a leading financial publication, is pleased to alert investors of stocks on the move. Sign Up for our Free Stock Newsletter
The Company’s CFO, John Thero, is going to be participating in the Needham & Co. 9th Annual Healthcare Conference. The Company is scheduled to present at 4:40pm (ET) on June 9, 2010. The event is taking place in NYC at the New York Palace Hotel.
Amarin is a clinical-stage biopharmaceutical company with expertise in lipid science focused the treatment of cardiovascular disease.
Sign up for Top Best Penny Stocks' free newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website
About Us
Top Best Penny Stocks is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer
